Funder
KU Leuven
Fonds Wetenschappelijk Onderzoek
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference5 articles.
1. Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T et al (2022) Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med 48(3):311–321
2. Committee for Medicinal Products for Human Use (2016) Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antimicrobial medicinal products. European Medicines Agency. https://www.ema.europa.eu/en/use-pharmacokinetics-pharmacodynamicsdevelopment-antibacterial-medicinal-products. Accessed 28 Feb 2022
3. Wicha SG, Martson AG, Nielsen EI, Koch BCP, Friberg LE, Alffenaar JW et al (2021) From therapeutic drug monitoring to model-informed precision dosing for antibiotics. Clin Pharmacol Ther 109(4):928–941
4. El-Haffaf I, Caissy JA, Marsot A (2021) Piperacillin-tazobactam in intensive care units: a review of population pharmacokinetic analyses. Clin Pharmacokinet 60(7):855–875
5. Weinelt FA, Stegemann MS, Theloe A, Pfäfflin F, Achterberg S, Schmitt L et al (2021) Development of a model-informed dosing tool to optimise initial antibiotic dosing-A translational example for Intensive Care Units. Pharmaceutics 13(12):2128
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献